Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,725 | 104 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $291.62 | 19 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $243.34 | 15 | $0 (2021) |
| Novo Nordisk Inc | $171.47 | 10 | $0 (2022) |
| ABBVIE INC. | $160.07 | 8 | $0 (2022) |
| Allergan, Inc. | $120.29 | 6 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $89.57 | 6 | $0 (2021) |
| Amgen Inc. | $82.69 | 5 | $0 (2022) |
| PFIZER INC. | $70.65 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.13 | 4 | $0 (2022) |
| Lilly USA, LLC | $39.24 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $210.37 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.84) |
| 2021 | $562.16 | 33 | AbbVie Inc. ($112.42) |
| 2020 | $315.77 | 18 | AstraZeneca Pharmaceuticals LP ($76.10) |
| 2019 | $339.31 | 22 | Janssen Pharmaceuticals, Inc ($83.65) |
| 2018 | $167.73 | 11 | Amgen Inc. ($27.37) |
| 2017 | $129.19 | 9 | Valeant Pharmaceuticals North America LLC ($31.55) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Diabetes | ||||||
| 04/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: DIABETES | ||||||
| 04/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Womens Health | ||||||
| 04/04/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiovascular | ||||||
| 03/22/2022 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Neuroscience | ||||||
| 03/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: PRIMARY CARE | ||||||
| 02/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Respiratory | ||||||
| 12/14/2021 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROLOGY | ||||||
| 11/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINES | ||||||
| 11/16/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Obesity | ||||||
| 09/28/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $17.42 | General |
| 09/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Neuroscience | ||||||
| 09/01/2021 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Respiratory | ||||||
| 08/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 310 | 346 | $25,692 | $15,016 |
| 2021 | 16 | 821 | 1,136 | $73,131 | $47,689 |
| 2020 | 21 | 862 | 1,149 | $90,326 | $54,564 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 81 | $11,492 | $6,250 | 54.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $6,097 | $5,514 | 90.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 60 | $5,798 | $2,575 | 44.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 64 | 77 | $1,386 | $230.73 | 16.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 22 | $440.00 | $212.72 | 48.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 52 | 53 | $371.00 | $184.14 | 49.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 12 | 12 | $108.00 | $48.00 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 124 | 224 | $31,472 | $19,449 | 61.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $11,876 | $10,710 | 90.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 118 | $11,429 | $6,711 | 58.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 23 | $4,314 | $2,851 | 66.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 42 | 42 | $2,940 | $2,741 | 93.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,430 | $1,373 | 96.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 43 | 43 | $1,075 | $753.79 | 70.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 149 | 247 | $4,366 | $735.30 | 16.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 43 | 67 | $1,340 | $641.67 | 47.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 119 | 161 | $1,127 | $556.80 | 49.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 19 | 19 | $350.00 | $324.65 | 92.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 18 | 18 | $453.96 | $315.86 | 69.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 19 | 28 | $280.00 | $174.44 | 62.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $308.00 | $158.47 | 51.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 19 | 28 | $280.00 | $145.04 | 51.8% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 11 | 14 | $90.44 | $48.24 | 53.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 252 | $34,582 | $18,214 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 76 | 76 | $11,205 | $9,103 | 81.2% |
About Dr. John Draper, MD
Dr. John Draper, MD is a Family Medicine healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174541817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Draper, MD has received a total of $1,725 in payments from pharmaceutical and medical device companies, with $210.37 received in 2022. These payments were reported across 104 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,725).
As a Medicare-enrolled provider, Draper has provided services to 1,993 Medicare beneficiaries, totaling 2,631 services with total Medicare billing of $117,269. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Aurora, CO
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174541817
Products in Payments
- XARELTO (Drug) $232.07
- FARXIGA (Drug) $156.48
- VRAYLAR (Drug) $118.48
- JANUVIA (Drug) $73.82
- UBRELVY (Drug) $69.55
- Saxenda (Drug) $68.77
- Ozempic (Drug) $61.80
- SYMBICORT (Drug) $60.29
- Aimovig (Biological) $55.32
- NURTEC ODT (Drug) $46.61
- QULIPTA (Drug) $38.22
- JARDIANCE (Drug) $35.75
- SPIRIVA RESPIMAT (Drug) $34.38
- PREVNAR 13 (Biological) $32.72
- Vascepa (Drug) $30.84
- Synthroid (Drug) $30.48
- BREZTRI (Drug) $28.67
- Repatha (Biological) $27.37
- XIFAXAN (Drug) $26.10
- CHANTIX (Drug) $25.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Aurora
Matthew Lewis, Md, MD
Family Medicine — Payments: $36,183
Sean Oser, Md, MD
Family Medicine — Payments: $21,542
Timothy Colander, Md, MD
Family Medicine — Payments: $16,077
Dr. Sean Kennedy, M.d, M.D
Family Medicine — Payments: $15,418
Christopher Stallter, D.o, D.O
Family Medicine — Payments: $14,077
Gina Lesnik, D.o, D.O
Family Medicine — Payments: $12,953